| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.065 | 0.03 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |